Anika Therapeutics (ANIK) Goodwill & Intangibles (2010 - 2026)

Anika Therapeutics (ANIK) has 17 years of Goodwill & Intangibles data on file, last reported at $9.6 million in Q1 2026.

• Goodwill & Intangibles for Q1 2026 came in at $9.6 million, up 5.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.6 million (up 5.14% YoY), and the FY2025 annual result was $9.7 million, down 64.01% from the prior year.
• Goodwill & Intangibles fell to $9.6 million in Q1 2026 per ANIK's latest filing, from $9.7 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $119.5 million in Q4 2022 and troughed at $8.3 million in Q3 2024.
• A 5-year average of $51.5 million and a median of $57.3 million in 2024 frame the typical range for Goodwill & Intangibles.
• On a YoY basis, Goodwill & Intangibles climbed as much as 165.7% in 2024 and fell as far as 93.08% in 2024.
• A 5-year view of Goodwill & Intangibles shows it stood at $119.5 million in 2022, then sank by 91.51% to $10.1 million in 2023, then soared by 165.7% to $27.0 million in 2024, then sank by 64.01% to $9.7 million in 2025, then decreased by 1.15% to $9.6 million in 2026.
• Business Quant data shows ANIK's Goodwill & Intangibles at $9.6 million in Q1 2026, $9.7 million in Q4 2025, and $9.7 million in Q3 2025.